umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Bisfosfonatbehandlingkan orsakastressfraktur: men behandlingsnyttan ärbetydligt större än risken
Ortopedkliniken, Sundsvalls sjukhus.
Ortopedkliniken, Sundsvalls sjukhus.
Ortopedkliniken, Sundsvalls sjukhus.
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience, Clinical Pharmacology.
2010 (Swedish)In: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 107, no 41, 2482-3 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2010. Vol. 107, no 41, 2482-3 p.
Keyword [sv]
alendronat, medel för bevarande av bentäthet, lårbensfrakturer, utmattningsfrakturer, riskfaktorer
Identifiers
URN: urn:nbn:se:umu:diva-42536PubMedID: 21137565OAI: oai:DiVA.org:umu-42536DiVA: diva2:409515
Note
Eng.titel i PubMed: Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the riskAvailable from: 2011-04-08 Created: 2011-04-08 Last updated: 2017-12-11Bibliographically approved

Open Access in DiVA

No full text

PubMed

Search in DiVA

By author/editor
Pettersson, Ulrika
By organisation
Clinical Pharmacology
In the same journal
Läkartidningen

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 58 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf